Biomarkers of susceptibility to chemical carcinogens: the example of non-Hodgkin lymphomas

被引:8
|
作者
Kelly, Rachel S. [1 ,2 ]
Vineis, Paolo [2 ,3 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, London W2 1PG, England
[3] HuGef Fdn, Turin, Italy
基金
英国经济与社会研究理事会;
关键词
biomarkers of susceptibility; chemical carcinogens; xenobiotic metabolism pathways; non-Hodgkin lymphoma; gene-environment interaction; GENE-ENVIRONMENT INTERACTIONS; OCCUPATIONAL SOLVENT EXPOSURE; DNA-REPAIR GENES; SEX-DIFFERENCES; POOLED ANALYSIS; RISK; POLYMORPHISMS; ASSOCIATION; EPIDEMIOLOGY; IMMUNE;
D O I
10.1093/bmb/ldu015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Genetic susceptibly to suspected chemical and environmental carcinogens may modify the response to exposure. The aim of this review was to explore the issues involved in the study of gene-environment interactions, and to consider the use of susceptibility biomarkers in cancer epidemiology, using non-Hodgkin lymphoma (NHL) as an example. Sources of data: PubMed, EMBASE and Web of Science were searched for peer-reviewed articles considering biomarkers of susceptibility to chemical, agricultural and industrial carcinogens in the aetiology of NHL. Areas of agreement: The results suggest a modifying role for genetic susceptibility to a number of occupational and environmental exposures including organochlorines, chlorinated solvents, chlordanes and benzene in the aetiology of NHL. The potential importance of these gene-environment interactions in NHL may help to explain the lack of definitive carcinogens identified to date for this malignancy. Areas of controversy: Although a large number of genetic variants and gene-environment interactions have been explored for NHL, to date replication is lacking and therefore the findings remain to be validated. Growing points and areas timely for developing research: These findings highlight the need for novel standardized methodologies in the study of genetic susceptibility to chemical carcinogens.
引用
收藏
页码:89 / 100
页数:12
相关论文
共 50 条
  • [21] Non-Hodgkin lymphomas and carrier state of viral hepatitis B and C
    Grudeva-Popova, J.
    Nenova, I.
    Mateva, N.
    Ananoshtev, N.
    Popov, V.
    Atanasova, M.
    JOURNAL OF BUON, 2013, 18 (01): : 239 - 244
  • [22] COVID-19 and non-Hodgkin's lymphoma: A common susceptibility pattern?
    Sara, De Matteis
    Minelli, Cosetta
    Broccia, Giorgio
    Vineis, Paolo
    Cocco, Pierluigi
    PLOS ONE, 2023, 18 (03):
  • [23] Non-Hodgkin lymphomas in pregnancy: Tackling therapeutic quandaries
    Avivi, Irit
    Farbstein, Dan
    Brenner, Benjamin
    Horowitz, Netanel A.
    BLOOD REVIEWS, 2014, 28 (05) : 213 - 220
  • [24] Insights into Diagnosis and Treatment of Nasopharyngeal Non-Hodgkin Lymphomas
    Musteata, Vasile
    Nichifor, Lilian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S381 - S382
  • [25] HCV infection and non-Hodgkin lymphomas: an evolving story
    Defrancesco, Irene
    Zerbi, Caterina
    Rattotti, Sara
    Merli, Michele
    Bruno, Raffaele
    Paulli, Marco
    Arcaini, Luca
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (03) : 321 - 328
  • [26] Alterations in regulators of the extracellular matrix in non-Hodgkin lymphomas
    Negaard, Helene F. S.
    Svennevig, Katja
    Kolset, Svein Olav
    Iversen, Nina
    Lothe, Inger Marie Bowitz
    Ostenstad, Bjorn
    Sandset, Per Morten
    Iversen, Per Ole
    LEUKEMIA & LYMPHOMA, 2009, 50 (06) : 998 - 1004
  • [27] Incidence and outcomes of rare paediatric non-hodgkin lymphomas
    Sorge, Caryn
    Costa, Luciano J.
    Taub, Jeffrey W.
    Cairo, Mitchell S.
    Xavier, Ana C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (05) : 864 - 867
  • [28] FPA micro spectral imaging of non-Hodgkin lymphomas
    Burattini, E.
    Malvezzi-Campeggi, F.
    Chilosi, M.
    Conti, C.
    Ferraris, P.
    Monti, F.
    Sabbatini, S.
    Tosi, G.
    Zamo, A.
    JOURNAL OF MOLECULAR STRUCTURE, 2007, 834 : 170 - 175
  • [29] Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas
    Watanabe, Takashi
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (09) : 1113 - 1127
  • [30] NON-HODGKIN LYMPHOMAS OF THE CENTRAL-NERVOUS-SYSTEM
    PISANI, F
    ANTIMI, M
    CANTONETTI, M
    MARCIANI, MG
    MASI, M
    TRIBALTO, M
    PAPA, G
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1991, 12 (05): : 453 - 459